索引超出了数组界限。
[1] Deng D, Liu L, Xu G, et al. Epidemiology and serum metabolic characteristics of acute myocardial infarction patients in chest pain centers[J]. Iran J Public Health, 2018, 47(7):1017-1029.
[2] Chen Z, Li C, Lin K, et al. MicroRNAs in acute myocardial infarction: evident value as novel biomarkers?[J]. Anatol J Cardiol, 2018, 19(2):140-147.
[3] Li G, Song Y, Li YD, et al. Circulating miRNA-302 family members as potential biomarkers for the diagnosis of acute heart failure[J]. Biomark Med, 2018, 12(8):871-880.
[4] Mendis S, Thygesen K, Kuulasmaa KA, et al. World Health Organization definition of myocardial infarction: 2008-09 revision[J]. Int J Epidemiol, 2011, 40(1):139-146.
[5] Mueller C, Auer J, Halvorsen S. Cardiac troponin elevations in acute non-coronary disease: helpful or not?[J]. Eur Heart J Acute Cardiovasc Care, 2015, 4(5):429-430.
[6] Eggers KM, Lindahl B. Application of cardiac troponin in cardiovascular diseases other than acute coronary syndrome[J]. Clin Chem, 2017, 63(1):223-235.
[7] Wu K, Zhao Q, Li Z, et al. Bioinformatic screening for key miRNAs and genes associated with myocardial infarction[J]. FEBS Open Bio, 2018, 8(6):897-913.
[8] Sun T, Dong YH, Du W, et al. The role of MicroRNAs in myocardial infarction: from molecular mechanism to clinical application[J]. Int J Mol Sci, 2017, 18(4):e745.
[9] Fan J, Ma J, Xia N, et al. Clinical value of combined detection of CK-MB, MYO, cTnI and plasma NT-proBNP in diagnosis of acute myocardial infarction[J]. Clin Lab, 2017, 63(3):427-433.
[10] 陈劲松, 刘访遥, 刘运阳, 等. miR-214在老年急性心肌梗死患者血清中的表达及其临床意义[J]. 中国急救医学, 2018, 38(4):341-344.
[11] Guo ML, Guo LL, Weng YQ. Implication of peripheral blood miRNA-124 in predicting acute myocardial infarction[J]. Eur Rev Med Pharmacol Sci, 2017, 21(5):1054-1059.
[12] Yang S, Fu C, Xu R, et al. Serum microRNA-302b: the novel biomarker for diagnosis of acute myocardial infarction[J]. Br J Biomed Sci, 2017, 74(4):214-216.